Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1976 3
1977 1
1978 1
1980 3
1981 2
1989 1
1990 1
1991 1
1993 1
1998 1
2000 1
2003 2
2004 5
2005 1
2008 1
2013 1
2014 2
2015 2
2019 4
2020 1
2021 7
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Transfusion Support.
Schrezenmeier H, Körper S, Höchsmann B, Weinstock C. Schrezenmeier H, et al. Among authors: korper s. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 23. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 23. PMID: 32091790 Free Books & Documents. Review.
Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19.
Körper S, Weiss M, Zickler D, Wiesmann T, Zacharowski K, Corman VM, Grüner B, Ernst L, Spieth P, Lepper PM, Bentz M, Zinn S, Paul G, Kalbhenn J, Dollinger MM, Rosenberger P, Kirschning T, Thiele T, Appl T, Mayer B, Schmidt M, Drosten C, Wulf H, Kruse JM, Jungwirth B, Seifried E, Schrezenmeier H; CAPSID Clinical Trial Group. Körper S, et al. J Clin Invest. 2021 Oct 15;131(20):e152264. doi: 10.1172/JCI152264. J Clin Invest. 2021. PMID: 34464358 Free PMC article. Clinical Trial.
[Aplastic anemia].
Schrezenmeier H, Körper S, Höchsmann B. Schrezenmeier H, et al. Among authors: korper s. Dtsch Med Wochenschr. 2014 Dec;139(49):2503-6. doi: 10.1055/s-0034-1387407. Epub 2014 Nov 25. Dtsch Med Wochenschr. 2014. PMID: 25423456 Review. German. No abstract available.
Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors.
Jahrsdörfer B, Groß R, Seidel A, Wettstein L, Ludwig C, Schwarz T, Körper S, Rojewski M, Lotfi R, Weinstock C, Seifried E, Corman VM, Drosten C, Münch J, Schrezenmeier H. Jahrsdörfer B, et al. Among authors: korper s. J Immunol. 2021 Jun 1;206(11):2614-2622. doi: 10.4049/jimmunol.2100036. Epub 2021 May 12. J Immunol. 2021. PMID: 33980583
Granulocyte transfusions - bridging to allogeneic hematopoietic stem cell transplantation.
Nguyen TM, Scholl K, Idler I, Wais V, Körper S, Lotfi R, Bommer M, Wiesneth M, Schrezenmeier H, Döhner H, Bohl SR, Harsdorf SV, Reinhardt P, Bunjes D, Ringhoffer M, Kuchenbauer F. Nguyen TM, et al. Among authors: korper s. Leuk Lymphoma. 2020 Feb;61(2):481-484. doi: 10.1080/10428194.2019.1660977. Epub 2019 Sep 24. Leuk Lymphoma. 2020. PMID: 31547738 No abstract available.
mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects.
Fabricius D, Ludwig C, Scholz J, Rode I, Tsamadou C, Jacobsen EM, Winkelmann M, Grempels A, Lotfi R, Janda A, Körper S, Adler G, Debatin KM, Schrezenmeier H, Jahrsdörfer B. Fabricius D, et al. Among authors: korper s. Vaccines (Basel). 2021 Aug 18;9(8):918. doi: 10.3390/vaccines9080918. Vaccines (Basel). 2021. PMID: 34452043 Free PMC article.
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies.
Körper S, Jahrsdörfer B, Corman VM, Pilch J, Wuchter P, Blasczyk R, Müller R, Tonn T, Bakchoul T, Schäfer R, Juhl D, Schwarz T, Gödecke N, Burkhardt T, Schmidt M, Appl T, Eichler H, Klüter H, Drosten C, Seifried E, Schrezenmeier H. Körper S, et al. Transfus Med Hemother. 2021 May;48(3):137-147. doi: 10.1159/000515610. Epub 2021 Apr 21. Transfus Med Hemother. 2021. PMID: 34177417 Free PMC article.
43 results